We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns of Potential API Contamination From Chinese Plant
FDA Warns of Potential API Contamination From Chinese Plant
The FDA issued a warning that active pharmaceutical ingredient baclofen manufactured by Taizhou Xinyou Pharmaceutical & Co. Limited, may be at risk for contamination and should not be used to compound sterile injectable drugs.